Our Solutions

Take a Virtual Tour of our State‑of‑the‑Art Preclinical Facility

 

With over 25 years’ experience conducting safety assessment, Altasciences’ preclinical facility in Seattle offers a wide array of solutions, including IND/CTA and NDA-enabling safety assessment, as well as laboratory services for both small and large molecules. 

In this 210,000-square-foot, purpose-built facility, Altasciences can thoroughly assess the safety of your molecules with a full range of in vivo GLP and non-GLP preclinical evaluation studies in both rodent and non-rodent species. We’ve conducted over 2,400 safety studies at this site, which features:

  • 140 custom-design animal rooms, including European housing 
  • 4,500 sq.-ft. archive facility 
  • Capacity to house ~3,000 NHPs, ~500 Canines, ~100 Swine, ~12,000 Rodents, ~800 Rabbits
  • AAALAC accreditation 
  • USDA registration
  • OLAW assurance
  • BSL-2 certification

Catch a glimpse of the facility here.

Catch a glimpse of our preclinical facility

Request a full virtual tour of our Seattle site or contact us for more information on our newest preclinical site in Scranton.

You may also be interested in the following:

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Working as a flexible, attentive extension of your team, we offer comprehensive drug development services to move your molecule forward.

Sign up for exclusive content

Join our list of 10,000+ VIP members and have access to our exclusive content.

You can unsubscribe at any time. For more details, please review our privacy policy.

Stay connected